The Barth Syndrome Foundation's Board of Directors is responsible for overseeing the mission and purpose of the organization. Its duties include participation in strategic planning and making policy decisions, then securing the financing of them and the monitoring of their execution. Members must be willing to attend the requisite meetings, follow through on commitments, and participate fully in the decision-making process. The board also presents the organization´s image to the community and solicits its support in achieving BSF´s goals. Members of the BSF Board of Directors serve three-year terms. For all correspondence, including information, please contact us.
Miriam L. Greenberg, PhD
Dr. Greenberg is a Professor of Biological Sciences at Wayne State University in Detroit, MI. She is an expert on phospholipid metabolism in yeast and brings a wealth of knowledge about cardiolipin that has and will continue to advance scientific knowledge about some of the underlying biochemical issues in Barth syndrome.
Miriam joined our Scientific and Medical Advisory Board (SMAB) in 2005 and has been an important member ever since. She has helped in the organization of several of our Scientific and Medical Conferences and frequently brings her family to attend as well. Starting with an original focus on cardiolipin and the yeast model system, she has been awarded 12 BSF research grants over the years to explore various topics in lipid metabolism that are relevant to our disease. She is a highly-respected researcher on the underlying science of Barth syndrome and has been successful in leveraging the BSF seed grants into additional, larger funding from other institutions.
